They also found that the pharmacological inhibitor α-MT inhibited cell proliferation and the fact that SLC6A14 promoted colorectal cancer cell proliferation and migration via the JAK2/STAT3 pathway. This evidence concerns the gene SLC6A14 and colorectal cancer.